KEWAUNEE SCIENTIFIC CP (KEQU) Fundamental Analysis & Valuation

NASDAQ:KEQU • US4928541048

41.85 USD
+0.85 (+2.07%)
Last: Mar 6, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This KEQU fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall KEQU gets a fundamental rating of 5 out of 10. We evaluated KEQU against 184 industry peers in the Health Care Equipment & Supplies industry. KEQU has only an average score on both its financial health and profitability. KEQU has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. KEQU Profitability Analysis

1.1 Basic Checks

  • KEQU had positive earnings in the past year.
  • KEQU had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: KEQU reported negative net income in multiple years.
  • In multiple years KEQU reported negative operating cash flow during the last 5 years.
KEQU Yearly Net Income VS EBIT VS OCF VS FCFKEQU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M

1.2 Ratios

  • KEQU has a Return On Assets of 6.21%. This is amongst the best in the industry. KEQU outperforms 83.70% of its industry peers.
  • KEQU's Return On Equity of 16.81% is amongst the best of the industry. KEQU outperforms 91.85% of its industry peers.
  • The Return On Invested Capital of KEQU (10.67%) is better than 90.76% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for KEQU is in line with the industry average of 9.15%.
  • The 3 year average ROIC (9.90%) for KEQU is below the current ROIC(10.67%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.21%
ROE 16.81%
ROIC 10.67%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
KEQU Yearly ROA, ROE, ROICKEQU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • KEQU has a better Profit Margin (4.11%) than 76.09% of its industry peers.
  • The Operating Margin of KEQU (6.89%) is better than 72.28% of its industry peers.
  • KEQU's Gross Margin of 29.09% is on the low side compared to the rest of the industry. KEQU is outperformed by 75.54% of its industry peers.
  • In the last couple of years the Gross Margin of KEQU has grown nicely.
Industry RankSector Rank
OM 6.89%
PM (TTM) 4.11%
GM 29.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
KEQU Yearly Profit, Operating, Gross MarginsKEQU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. KEQU Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), KEQU is creating some value.
  • KEQU has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for KEQU has been increased compared to 5 years ago.
  • KEQU has a worse debt/assets ratio than last year.
KEQU Yearly Shares OutstandingKEQU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
KEQU Yearly Total Debt VS Total AssetsKEQU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 3.37 indicates that KEQU is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of KEQU (3.37) is better than 71.20% of its industry peers.
  • KEQU has a debt to FCF ratio of 12.32. This is a negative value and a sign of low solvency as KEQU would need 12.32 years to pay back of all of its debts.
  • KEQU's Debt to FCF ratio of 12.32 is fine compared to the rest of the industry. KEQU outperforms 71.74% of its industry peers.
  • KEQU has a Debt/Equity ratio of 0.85. This is a neutral value indicating KEQU is somewhat dependend on debt financing.
  • KEQU has a worse Debt to Equity ratio (0.85) than 72.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 12.32
Altman-Z 3.37
ROIC/WACC1.08
WACC9.9%
KEQU Yearly LT Debt VS Equity VS FCFKEQU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • KEQU has a Current Ratio of 2.48. This indicates that KEQU is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.48, KEQU is in line with its industry, outperforming 49.46% of the companies in the same industry.
  • A Quick Ratio of 1.71 indicates that KEQU should not have too much problems paying its short term obligations.
  • The Quick ratio of KEQU (1.71) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 1.71
KEQU Yearly Current Assets VS Current LiabilitesKEQU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. KEQU Growth Analysis

3.1 Past

  • The earnings per share for KEQU have decreased strongly by -37.55% in the last year.
  • Looking at the last year, KEQU shows a very strong growth in Revenue. The Revenue has grown by 43.02%.
  • Measured over the past years, KEQU shows a quite strong growth in Revenue. The Revenue has been growing by 10.27% on average per year.
EPS 1Y (TTM)-37.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.15%
Revenue 1Y (TTM)43.02%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.76%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KEQU Yearly Revenue VS EstimatesKEQU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
KEQU Yearly EPS VS EstimatesKEQU Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. KEQU Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.29, the valuation of KEQU can be described as very reasonable.
  • KEQU's Price/Earnings ratio is rather cheap when compared to the industry. KEQU is cheaper than 95.11% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of KEQU to the average of the S&P500 Index (26.29), we can say KEQU is valued rather cheaply.
Industry RankSector Rank
PE 8.29
Fwd PE N/A
KEQU Price Earnings VS Forward Price EarningsKEQU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • KEQU's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. KEQU is cheaper than 97.83% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 86.41% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 23.45
EV/EBITDA 6.53
KEQU Per share dataKEQU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The decent profitability rating of KEQU may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. KEQU Dividend Analysis

5.1 Amount

  • KEQU does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KEQU Fundamentals: All Metrics, Ratios and Statistics

KEWAUNEE SCIENTIFIC CP

NASDAQ:KEQU (3/6/2026, 8:00:02 PM)

41.85

+0.85 (+2.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)12-10
Earnings (Next)03-11
Inst Owners41.72%
Inst Owner Change3.9%
Ins Owners15.69%
Ins Owner Change-3.83%
Market Cap120.11M
Revenue(TTM)285.51M
Net Income(TTM)11.74M
Analysts82.86
Price TargetN/A
Short Float %1.54%
Short Ratio6.6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.29
Fwd PE N/A
P/S 0.42
P/FCF 23.45
P/OCF 13.86
P/B 1.72
P/tB 2.98
EV/EBITDA 6.53
EPS(TTM)5.05
EY12.07%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.78
FCFY4.26%
OCF(TTM)3.02
OCFY7.22%
SpS99.48
BVpS24.34
TBVpS14.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number52.59
Profitability
Industry RankSector Rank
ROA 6.21%
ROE 16.81%
ROCE 13.73%
ROIC 10.67%
ROICexc 11.69%
ROICexgc 15.07%
OM 6.89%
PM (TTM) 4.11%
GM 29.09%
FCFM 1.79%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score4
Asset Turnover1.51
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 12.32
Debt/EBITDA 2.29
Cap/Depr 56.58%
Cap/Sales 1.24%
Interest Coverage 250
Cash Conversion 33.42%
Profit Quality 43.61%
Current Ratio 2.48
Quick Ratio 1.71
Altman-Z 3.37
F-Score4
WACC9.9%
ROIC/WACC1.08
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)43.02%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1290.93%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y51.55%
OCF growth 3YN/A
OCF growth 5Y28.86%

KEWAUNEE SCIENTIFIC CP / KEQU FAQ

What is the ChartMill fundamental rating of KEWAUNEE SCIENTIFIC CP (KEQU) stock?

ChartMill assigns a fundamental rating of 5 / 10 to KEQU.


What is the valuation status of KEWAUNEE SCIENTIFIC CP (KEQU) stock?

ChartMill assigns a valuation rating of 5 / 10 to KEWAUNEE SCIENTIFIC CP (KEQU). This can be considered as Fairly Valued.


How profitable is KEWAUNEE SCIENTIFIC CP (KEQU) stock?

KEWAUNEE SCIENTIFIC CP (KEQU) has a profitability rating of 6 / 10.


How financially healthy is KEWAUNEE SCIENTIFIC CP?

The financial health rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 5 / 10.


Is the dividend of KEWAUNEE SCIENTIFIC CP sustainable?

The dividend rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 0 / 10 and the dividend payout ratio is 0%.